Utah Medical Products repurchases 322,215 shares for $24.17 million
UTMD•Utah Medical Products repurchased 322,215 shares for $24.17 million through a tender offer that expired Oct. 27, 2026. The effective cost was $75.36 per share, excluding a 1% federal excise tax.
1. Tender offer results
Utah Medical Products repurchased 322,215 common shares for $24.17 million through its tender offer, which offered $75 per share for up to 650,000 shares and expired Oct. 27, 2026. The effective repurchase cost was $75.36 per share, excluding a further 1% federal excise tax. Shares outstanding totaled 2,854,566 as of Oct. 29, including 1,775 shares issued through employee option exercises in October.
